210 related articles for article (PubMed ID: 10193775)
1. Inhibition of the production of endothelium-derived hyperpolarizing factor by cannabinoid receptor agonists.
Fleming I; Schermer B; Popp R; Busse R
Br J Pharmacol; 1999 Feb; 126(4):949-60. PubMed ID: 10193775
[TBL] [Abstract][Full Text] [Related]
2. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.
White R; Hiley CR
Br J Pharmacol; 1997 Dec; 122(8):1573-84. PubMed ID: 9422801
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid CB1 receptor and endothelium-dependent hyperpolarization in guinea-pig carotid, rat mesenteric and porcine coronary arteries.
Chataigneau T; Félétou M; Thollon C; Villeneuve N; Vilaine JP; Duhault J; Vanhoutte PM
Br J Pharmacol; 1998 Mar; 123(5):968-74. PubMed ID: 9535027
[TBL] [Abstract][Full Text] [Related]
4. Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries.
Plane F; Holland M; Waldron GJ; Garland CJ; Boyle JP
Br J Pharmacol; 1997 Aug; 121(8):1509-11. PubMed ID: 9283682
[TBL] [Abstract][Full Text] [Related]
5. The effects of Delta9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide.
O'Sullivan SE; Kendall DA; Randall MD
Br J Pharmacol; 2005 Jun; 145(4):514-26. PubMed ID: 15821751
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211
[TBL] [Abstract][Full Text] [Related]
7. Studies on the effects of anandamide in rat hepatic artery.
Zygmunt PM; Högestätt ED; Waldeck K; Edwards G; Kirkup AJ; Weston AH
Br J Pharmacol; 1997 Dec; 122(8):1679-86. PubMed ID: 9422814
[TBL] [Abstract][Full Text] [Related]
8. N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor.
Pratt PF; Hillard CJ; Edgemond WS; Campbell WB
Am J Physiol; 1998 Jan; 274(1):H375-81. PubMed ID: 9458889
[TBL] [Abstract][Full Text] [Related]
9. Mesenteric vasodilation mediated by endothelial anandamide receptors.
Wagner JA; Varga K; Járai Z; Kunos G
Hypertension; 1999 Jan; 33(1 Pt 2):429-34. PubMed ID: 9931142
[TBL] [Abstract][Full Text] [Related]
10. Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation.
Randall MD; Kendall DA
Eur J Pharmacol; 1997 Sep; 335(2-3):205-9. PubMed ID: 9369375
[TBL] [Abstract][Full Text] [Related]
11. An endogenous cannabinoid as an endothelium-derived vasorelaxant.
Randall MD; Alexander SP; Bennett T; Boyd EA; Fry JR; Gardiner SM; Kemp PA; McCulloch AI; Kendall DA
Biochem Biophys Res Commun; 1996 Dec; 229(1):114-20. PubMed ID: 8954092
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.
White R; Ho WS; Bottrill FE; Ford WR; Hiley CR
Br J Pharmacol; 2001 Oct; 134(4):921-9. PubMed ID: 11606334
[TBL] [Abstract][Full Text] [Related]
13. Evidence against anandamide as the hyperpolarizing factor mediating the nitric oxide-independent coronary vasodilator effect of bradykinin in the rat.
Fulton D; Quilley J
J Pharmacol Exp Ther; 1998 Sep; 286(3):1146-51. PubMed ID: 9732371
[TBL] [Abstract][Full Text] [Related]
14. NO/PGI2-independent vasorelaxation and the cytochrome P450 pathway in rabbit carotid artery.
Dong H; Waldron GJ; Galipeau D; Cole WC; Triggle CR
Br J Pharmacol; 1997 Feb; 120(4):695-701. PubMed ID: 9051310
[TBL] [Abstract][Full Text] [Related]
15. A transferable, beta-naphthoflavone-inducible, hyperpolarizing factor is synthesized by native and cultured porcine coronary endothelial cells.
Popp R; Bauersachs J; Hecker M; Fleming I; Busse R
J Physiol; 1996 Dec; 497 ( Pt 3)(Pt 3):699-709. PubMed ID: 9003555
[TBL] [Abstract][Full Text] [Related]
16. Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures.
Molina-Holgado F; Molina-Holgado E; Guaza C; Rothwell NJ
J Neurosci Res; 2002 Mar; 67(6):829-36. PubMed ID: 11891798
[TBL] [Abstract][Full Text] [Related]
17. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics.
Fernández-Ruiz JJ; Muñoz RM; Romero J; Villanua MA; Makriyannis A; Ramos JA
Biochem Pharmacol; 1997 Jun; 53(12):1919-27. PubMed ID: 9256167
[TBL] [Abstract][Full Text] [Related]
18. Comparative pharmacology of endothelium-derived hyperpolarizing factor and anandamide in rat isolated mesentery.
Randall MD; McCulloch AI; Kendall DA
Eur J Pharmacol; 1997 Aug; 333(2-3):191-7. PubMed ID: 9314035
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor.
Bauersachs J; Popp R; Hecker M; Sauer E; Fleming I; Busse R
Circulation; 1996 Dec; 94(12):3341-7. PubMed ID: 8989149
[TBL] [Abstract][Full Text] [Related]
20. The extracellular regulated kinases (ERK) 1/2 mediate cannabinoid-induced inhibition of gap junctional communication in endothelial cells.
Brandes RP; Popp R; Ott G; Bredenkötter D; Wallner C; Busse R; Fleming I
Br J Pharmacol; 2002 Jul; 136(5):709-16. PubMed ID: 12086980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
